Status:
COMPLETED
Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission
Lead Sponsor:
Federico II University
Conditions:
Hodgkin Lymphoma
High Risk
Eligibility:
All Genders
18+ years
Brief Summary
Cohort study enrolled high-risk Hodgkin Lymphoma patients in first relapse after induction therapy followed after remission either with a systemic imaging-based surveillance (Imaging cohort) or with s...
Eligibility Criteria
Inclusion
- High risk Hodgkin Lymphoma
- achievement of complete response to first line therapy
Exclusion
- comorbidities that could impair participation in follow-up procedures
Key Trial Info
Start Date :
June 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT04298619
Start Date
June 1 2001
End Date
April 1 2019
Last Update
March 6 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.